Doctors could predict whether a man’s prostate cancer will be aggressive at the point of diagnosis – giving him the best ...

A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ...

People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of ...

Professor Amy Berrington explains how she and a team of scientists from around the world took on the challenge of updating a classic text for cancer researchers.

Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, ...

A new multimillion-pound research programme, involving scientists from The Institute of Cancer Research, London, is aiming to ...

Researchers are a step closer to revolutionising how doctors use radiotherapy to treat patients with muscle-invasive bladder ...

This series of courses is organised by the Joint Department of Physics of T he Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London. The courses provide the necessary ...

Image: DNA sequence. Credit: The Institute of Cancer Research, London. A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for one ...

The research undertaken at The Institute of Cancer Research is expanding our knowledge about this devastating disease and changing the way we treat it. A gift from you today could help us continue ...

The ICR-CTSU is a CR-UK funded, internationally recognised methodologist led clinical trials unit, providing cancer-focussed clinical trial research expertise. We lead pioneering, efficient, ...

Professor Janet Shipley is investigating ways to improve the treatment of patients with sarcomas that have a poor outcome. Group: Sarcoma Molecular Pathology 0000-0001-6748-8678 Originally from ...